
Join to view full profile
508 Fulton St# HemeDurham, NC 27705
Phone+1 919-286-0411
Fax+1 919-286-6896
Dr. Kelley is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Kelley is a medical oncologist based in Durham, NC, specializing in thoracic cancers. He completed his fellowship in medical oncology at the National Institutes of Health Clinical Center, following post-doctoral work at the National Cancer Institute. His residency in internal medicine was at Duke University Hospital, and he earned his medical degree from the University of Michigan Medical School. He is the 2026 of recipitent of ASCO's Humanitarian Award. Dr. Kelley has expertise in conditions such as lung cancer, mesothelioma and thymic malignancies. In addition to publications on lung cancer, his recent publications cover topics including cancer among women veterans and prostate cancer outcomes.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
National Cancer InstitutePost-Doctoral Fellowship, 1988 - 1990
Duke University HospitalResidency, Internal Medicine, 1985 - 1988
University of Michigan Medical SchoolClass of 1985
Certifications & Licensure
NC State Medical License 1998 - 2026
MI State Medical License 1993 - 2009
MD State Medical License 1989 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology
Publications & Presentations
PubMed
- Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans.Luca F Valle, Micaela Scobie, Kerry Rowe, Colin C Pritchard, Bruce Montgomery
The Oncologist. 2026-07-08 - Reconsidering community care referrals for Veterans with lung cancer.Drew Moghanaki, David H Harpole, Michael J Kelley
JNCI Cancer Spectrum. 2026-07-07 - Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.Martin W Schoen, Jiannong Li, Sihang Zeng, Heena Desai, Ryan Hausler
JCO Precision Oncology. 2026-07-01
Press Mentions
Delivering Precision Oncology to Improve Veteran CareSeptember 8th, 2020
Teleoncology in the Veterans Health Administration: Models of Care and the Veteran ExperienceJune 19th, 2024
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









